Summary of Presentations on HPV DNA QA Project
In order to further disseminate information and promote the importance of quality assurance for the testing of HPV DNA, members of the HPV committee will be presenting the information from this pilot study to participants and other interested parties for comment and feedback for future surveys.
- 20th June, 2008 – oral presentation of ‘HPV DNA Quality Assurance Pilot Study’ at the New Zealand Institute of Medical Laboratory Science, Immunology Special Interest Group Seminar (NZISIG) 2008. Deane Byers, RCPA Serology QAP.
- 2nd - 5th July, 2008 – oral presentation and poster titled ‘HPV DNA Quality Assurance Pilot Study’ at the 25th NRL Workshop on Serology in Melbourne, including an oral presentation on the 5th July. Ros Escott, RCPA Serology QAP
- 6th July, 2008 – oral presentation of ‘Human Papillomavirus DNA testing methodology and Quality Assurance’ at the Serology Sunday Workshop – part of the annual The Australian Society for Microbiology (ASM) 2008, Scientific Meeting & Exhibition in Melbourne. Assoc. Prof. Sepehr Tabrizi, The Royal Women's Hospital, VIC.
- 7th - 10th July, 2008 – poster titled ‘HPV DNA Quality Assurance Pilot Study’ will be on display at the Royal College of Pathology Australasia Quality Assurance Programs Pty Ltd booth at the annual The Australian Society for Microbiology (ASM) 2008, Scientific Meeting & Exhibition in Melbourne. Ros Escott and Deane Byers, RCPA Serology QAP.
- 13th - 17th October, 2008 – oral presentation of part of the work ‘Human Papillomavirus DNA testing methodology and Quality Assurance’ at the National Aust. Institute of Medical Scientist Annual Meeting in Melbourne. Assoc. Prof. Sepehr Tabrizi, The Royal Women's Hospital, VIC.
- 19th - 23rd October, 2008 – oral presentation of ‘Human Papillomavirus DNA testing methodology and Quality Assurance’ at the World congress of Cervical pathology and Colposcopy in Auckland. Assoc. Prof. Sepehr Tabrizi, The Royal Women's Hospital, VIC.
- 24th - 27th October, 2008 – oral presentation of ‘Human Papillomavirus DNA testing methodology and Quality Assurance’ at the Australian Society of Cytology in Sydney. Assoc. Prof. Sepehr Tabrizi, The Royal Women's Hospital, VIC.